ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/19035/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19035/49514_B_7_7_rna_selected_60x60.jpg) | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/2426/ihc_cell_selected_60x60.jpg) | ![](/images/2426/6196_B_7_3_rna_selected_60x60.jpg) | Group enriched |
ADGB | Androglobin | Enzymes
| | ![](/images/36341/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36340/75326_A_3_1_rna_selected_60x60.jpg) | Group enriched |
AKAP14 | A kinase (PRKA) anchor protein 14 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60999/137080_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ARMC3 | Armadillo repeat containing 3 | | | ![](/images/37824/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37823/77798_A_5_7_rna_selected_60x60.jpg) | Group enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11268/27966_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33630/80314_A_2_7_rna_selected_60x60.jpg) | Group enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38131/151682_A_3_1_rna_selected_60x60.jpg) | Group enriched |
C1orf167 | Chromosome 1 open reading frame 167 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39114/151335_B_8_2_rna_selected_60x60.jpg) | Group enriched |
C1orf194 | Chromosome 1 open reading frame 194 | | | ![](/images/31144/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49684/147542_B_7_2_rna_selected_60x60.jpg) | Group enriched |
C1orf87 | Chromosome 1 open reading frame 87 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31368/67807_B_8_2_rna_selected_60x60.jpg) | Group enriched |
C2orf81 | Chromosome 2 open reading frame 81 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49564/112471_A_3_3_rna_selected_60x60.jpg) | Group enriched |
CCDC19 | Coiled-coil domain containing 19 | | | | ![](/images_static/rna_center.gif) | ![](/images/43618/102476_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CCDC37 | Coiled-coil domain containing 37 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46354/103276_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CCDC96 | Coiled-coil domain containing 96 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47546/146625_B_3_5_rna_selected_60x60.jpg) | Group enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | ![](/images_static/rna_center.gif) | ![](/images/4003/141639_A_2_1_rna_selected_60x60.jpg) | Group enriched |
DAW1 | Dynein assembly factor with WDR repeat domains 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46118/101889_B_7_7_rna_selected_60x60.jpg) | Group enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26445/57583_A_4_3_rna_selected_60x60.jpg) | Group enriched |
DNAH12 | Dynein, axonemal, heavy chain 12 | Cancer-related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58203/149079_B_8_1_rna_selected_60x60.jpg) | Group enriched |
DNAI1 | Dynein, axonemal, intermediate chain 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images/21649/ihc_cell_selected_60x60.jpg) | ![](/images/21649/50472_A_1_6_rna_selected_60x60.jpg) | Group enriched |
DNAI2 | Dynein, axonemal, intermediate chain 2 | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images/6245/ihc_cell_selected_60x60.jpg) | ![](/images/6245/17134_A_3_1_rna_selected_60x60.jpg) | Group enriched |
DPYSL5 | Dihydropyrimidinase-like 5 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34544/73319_A_4_8_rna_selected_60x60.jpg) | Group enriched |
ELAVL2 | ELAV like neuron-specific RNA binding protein 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22222/151895_A_2_7_rna_selected_60x60.jpg) | Group enriched |
FAM181A | Family with sequence similarity 181, member A | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1603/5351_B_7_5_rna_selected_60x60.jpg) | Group enriched |
FAM69C | Family with sequence similarity 69, member C | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48928/110317_B_7_8_rna_selected_60x60.jpg) | Group enriched |
FHAD1 | Forkhead-associated (FHA) phosphopeptide binding domain 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54284/122605_B_3_5_rna_selected_60x60.jpg) | Group enriched |
GOLGA6B | Golgin A6 family, member B | | | ![](/images/45056/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44978/102776_B_8_5_rna_selected_60x60.jpg) | Group enriched |
HEMGN | Hemogen | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19604/50368_B_8_2_rna_selected_60x60.jpg) | Group enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62273/149779_A_1_2_rna_selected_60x60.jpg) | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | ![](/images/40454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40454/144750_A_5_1_rna_selected_60x60.jpg) | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/57112/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57112/140451_B_8_1_rna_selected_60x60.jpg) | Group enriched |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | ![](/images/275/1253_A_2_2_rna_selected_60x60.jpg) | Group enriched |
LRRC23 | Leucine rich repeat containing 23 | | | | ![](/images_static/rna_center.gif) | ![](/images/37766/146639_B_8_3_rna_selected_60x60.jpg) | Group enriched |
LRRC63 | Leucine rich repeat containing 63 | | | ![](/images/39763/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39318/86992_A_3_6_rna_selected_60x60.jpg) | Group enriched |
LRTOMT | Leucine rich transmembrane and O-methyltransferase domain containing | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images/39949/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39949/84581_A_1_1_rna_selected_60x60.jpg) | Group enriched |
MBD3L1 | Methyl-CpG binding domain protein 3-like 1 | | | ![](/images/43121/if_selected_60x60.jpg) | ![](/images/43121/ihc_cell_selected_60x60.jpg) | ![](/images/43121/94530_A_3_6_rna_selected_60x60.jpg) | Group enriched |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3084/8793_B_9_4_rna_selected_60x60.jpg) | Group enriched |
MNS1 | Meiosis-specific nuclear structural 1 | | | ![](/images/39975/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39975/95533_B_9_8_rna_selected_60x60.jpg) | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/16416/38770_B_9_1_rna_selected_60x60.jpg) | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40573/86487_B_7_8_rna_selected_60x60.jpg) | Group enriched |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/14509/ihc_cell_selected_60x60.jpg) | ![](/images/14509/34609_B_4_5_rna_selected_60x60.jpg) | Group enriched |
OTOA | Otoancorin | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41405/87538_B_9_1_rna_selected_60x60.jpg) | Group enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13138/30412_B_9_1_rna_selected_60x60.jpg) | Group enriched |
PFN3 | Profilin 3 | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47234/106029_B_9_7_rna_selected_60x60.jpg) | Group enriched |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | ![](/images_static/na_center.gif) | | ![](/images/44690/100195_A_2_3_rna_selected_60x60.jpg) | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47819/109921_B_1_3_rna_selected_60x60.jpg) | Group enriched |
PPP1R32 | Protein phosphatase 1, regulatory subunit 32 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39068/81496_B_8_2_rna_selected_60x60.jpg) | Group enriched |
RIBC2 | RIB43A domain with coiled-coils 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3210/9270_B_9_4_rna_selected_60x60.jpg) | Group enriched |
ROPN1L | Rhophilin associated tail protein 1-like | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41830/147865_B_8_5_rna_selected_60x60.jpg) | Group enriched |
RSPH9 | Radial spoke head 9 homolog (Chlamydomonas) | Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31703/65073_B_4_7_rna_selected_60x60.jpg) | Group enriched |